Shenaz Bagha is a medical editor at Healio. With a Bachelor of Arts in journalism and over 17 years of experience as a copy editor, she specializes in areas such as rheumatology, primary care, and psychiatry, while also covering broader topics in medicine and healthcare, including diagnostics and alternative medicine. Bagha's work has been featured in Healio, where she contributes her insights on pressing issues like the coronavirus, AI in healthcare, and FDA developments.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Shenaz Bagha's coverage predominantly focuses on medical research and healthcare, with an emphasis on citing data. She also includes expert commentary to provide context and insights into the scientific topics she covers.
Given her focus, Shenaz would likely be most responsive to pitches offering access to new and relevant data within the fields of medical research, rheumatology, biosimilars, autoimmune diseases or epilepsy. Pitches providing access to experts who can offer insightful commentary or analysis based on real-world evidence are also likely to resonate with her.
As Shenaz does not have a specific geographic focus indicated in her articles' titles or themes covered, it seems that she takes a broad view of these healthcare topics without being constrained by location.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Justin Cooper
Although sustained remission free of disease-modifying antirheumatic drugs “does not seem attainable” for patients with rheumatoid arthritis requiring biological DMARDs, it is possible for those who do not require them, according to data. The finding calls into question a EULAR recommendation, based on potentially flawed studies, discouraging DMARD cessation due to flare risks, Judith
Key takeaways: Exposure to nitrogen oxides increased risks for rheumatoid arthritis, Sjögren's and systemic lupus erythematosus.
By: Justin Cooper
Children with lupus nephritis who receive belimumab achieve treatment targets faster, and can taper glucocorticoids earlier, than those using standard immunotherapy, according to data published in Lupus Science & Medicine. “With the continuous advance of the pathogenesis of [systemic lupus erythematosus (SLE)]/[lupus nephritis], new medications such as belimumab have been developed and
By: Sarah Akerman, Robert Herpen, Shenaz Bagha
Video Player is loading. Play Video Play Mute Current Time Duration Loaded
By: Rob Volansky, Shenaz Bagha
The next phase of pre-exposure prophylaxis against SARS-CoV-2 currently rests on the shoulders of a single monoclonal antibody product — but it may not be enough for immunocompromised populations.
By: Robert Herpen, Shenaz Bagha
An interpretive machine learning model may be a feasible method for measuring agitation in dementia as well as in predicting certain environmental factors that are likely to contribute to the condition, according to a study.
By: Robert Herpen, Shenaz Bagha
Among post-9/11 United States military veterans, mild traumatic brain injury was associated with unfavorable long-term outcomes, such as severe PTSD, when occurring around a traumatic event, researchers wrote in JAMA Network Open
An analysis of adults with malignant glioma revealed that men were diagnosed at a younger age and women had worse preoperative status, but researchers found no other sex-related differences or clinical advantage.
By: Justin Cooper, Shenaz Bagha
A publicly funded exercise and education program for all patients awaiting joint replacements could reduce surgeries, alleviate wait times and result in net savings, according to data published in Arthritis Care & Research
Tracking lipid variability may be a reliable method of predicting dementia and cognitive decline among community-dwelling older adults, according to new research from Neurology.
(833) 317-6278 
